S, S., SP, N., S, G., L, F., V, A., KC, D. B., . . . R, F. (2026). Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases. Oncology and therapy. https://doi.org/10.1007/s40487-026-00433-y
Chicago Style (17th ed.) CitationS, Sidana, et al. "Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases." Oncology and Therapy 2026. https://doi.org/10.1007/s40487-026-00433-y.
MLA (9th ed.) CitationS, Sidana, et al. "Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases." Oncology and Therapy, 2026, https://doi.org/10.1007/s40487-026-00433-y.